To probe functionality of initial lymphatic vasculature within the tumor, we measured the expression of CCL21, a lymphatic endothelium-specific cytokine that attracts antigen-presenting cells, T-lymphocytes, and conversely metastatic cancer cells through CCR7 activation [43, 44]. This evidence concerns the gene CCL21 and neoplasm.